阿布罗西提尼布治疗局部类型的泛性银病:一个病例报告
Zhili Yang1, Jiejie Lu1, Zhen Li1
1Department of Dermatology, The Fifth People's Hospital of Hainan Province, Haikou, Hainan, People's Republic of China.
Clinical, cosmetic and investigational dermatology
|March 25, 2025
概括
阿布罗西替尼 (abrocitinib) 有效地治疗了一名局部泛性性牛皮 (GPP) 患者. 这个案例研究为abrocitinib提供了有价值的见解.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 泛性性牛皮 (GPP) 是一种严重的,反复复发的皮肤疾病.
- GPP可以呈现出广泛的病变或局部形式.
- 局部GPP的治疗选择有限,需要新的治疗方法.
研究的目的:
- 报告abrocitinib用于局部通用状牛皮的首次记录使用情况.
- 评估abrocitinib在这种特定GPP亚型中的临床疗效和安全性.
主要方法:
- 一份病例报告,详细介绍了局部GPP患者的治疗.
- 用于管理GPP病变的abrocitinib的管理.
- 对治疗反应和不良事件的临床评估.
主要成果:
- 阿布罗西替尼在治疗局部GPP方面表现出良好的临床疗效.
- 治疗耐受性很好,没有发现任何显著的副作用.
- 红血性斑块,皮和瘤的显著改善.
结论:
- 阿布罗西提尼布代表了局部GPP的潜在新疗法选择.
- 这个案例为abrocitinib在GPP管理中的使用提供了有价值的参考.
- 需要进一步的研究,以在更大的队列中证实这些发现.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
698
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
698
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
775
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
775
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
657
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
657
Pulmonary Tuberculosis IV
734
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
734
Staphylococcal Skin Infections
78
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
78
Acne Infection
58
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
58


